Erytech Pharma SA
PAR:ERYP
Cash Flow Statement
Cash Flow Statement
Erytech Pharma SA
| Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|
| Operating Cash Flow | ||||
| Net Income |
(73)
|
(54)
|
(0)
|
|
| Depreciation & Amortization |
5
|
5
|
5
|
|
| Other Non-Cash Items |
6
|
(1)
|
(29)
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
|
| Change in Working Capital |
11
|
(7)
|
(8)
|
|
| Cash from Operating Activities |
(52)
N/A
|
(57)
-10%
|
(32)
+44%
|
|
| Investing Cash Flow | ||||
| Capital Expenditures |
(1)
|
(0)
|
(0)
|
|
| Other Items |
(0)
|
(0)
|
38
|
|
| Cash from Investing Activities |
(1)
N/A
|
(0)
+77%
|
38
N/A
|
|
| Financing Cash Flow | ||||
| Net Issuance of Common Stock |
0
|
35
|
0
|
|
| Net Issuance of Debt |
25
|
10
|
(2)
|
|
| Other |
(0)
|
(0)
|
(0)
|
|
| Cash from Financing Activities |
25
N/A
|
45
+76%
|
(2)
N/A
|
|
| Change in Cash | ||||
| Effect of Foreign Exchange Rates |
(1)
|
2
|
0
|
|
| Net Change in Cash |
(29)
N/A
|
(11)
+63%
|
5
N/A
|
|
| Free Cash Flow | ||||
| Free Cash Flow |
(53)
N/A
|
(57)
-8%
|
(32)
+44%
|
|